Displaying drugs 2526 - 2550 of 2785 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Homosalate | 262.349 C16H22O3 | As ingredient in many sunscreen for protection against sunburn, skin aging and skin cancer. | Sunscreen Agents | |
Phenyl salicylate | 214.2167 C13H10O3 | Pain and fever . | Acids, Carbocyclic / Anti-Infective Agents, Local / Benzene Derivatives / Benzoates / Genito Urinary System and Sex Hormones / Hydroxy Acids / Hydroxybenzoates / Miscellaneous Analgesics and Antipyretics / Phenols / Urologicals | |
Hydroxychloroquine | 335.872 C18H26ClN3O | An antimalarial medication used to treat uncomplicated cases of malaria and for chemoprophylaxis in specific regions. Also a disease modifying anti-rheumatic drug (DMARD) indicated for treatment of rheumatoid arthritis and lupus erythematosus. | Aminoquinolines | |
Bromodiphenhydramine | 334.251 C17H20BrNO | For management of symptoms related to hay fever and other types of allergy and used to help bring up phlegm, thin secretions, and make a cough productive. | Aminoalkyl Ethers | |
Rabeprazole | 359.443 C18H21N3O3S | A proton pump inhibitor used to help gastrointestinal ulcers heal, to treat symptoms of gastroesophageal reflux disease (GERD), to eradicate Helicobacter pylori, and to treat hypersecretory conditions such as Zollinger-Ellison Syndrome. | Antiinflammatory Preparations, Non-Steroids for Topical Use / Butylpyrazolidines | |
Dexamethasone acetate | 434.4977 C24H31FO6 | Commonly known as decadron, dexamethasone acetate is a glucocorticosteroid previously marketed in the USA for the treatment of inflammatory respiratory, allergic, autoimmune, and other conditions.[T797,L10695,L14348] Developed in 1957, dexamethasone is... | Anti-Inflammatory Agents | |
Relebactam | 348.37 C12H20N4O6S | A beta-lactamase inhibitor used to prevent hydrolysis of beta-lactam antibiotics, leading to increased effectiveness. | beta-Lactamase Inhibitors | |
Diatrizoate | 613.9136 C11H9I3N2O4 | An injected contrast agent used in radiology. | Watersoluble, Nephrotropic, High Osmolar X-Ray Contrast Media | |
Trifluoperazine | 407.496 C21H24F3N3S | A phenothiazine used to treat depression, anxiety, and agitation. | Phenothiazines With Piperazine Structure | |
Anisindione | 252.2647 C16H12O3 | For the prophylaxis and treatment of venous thrombosis and its extension, the treatment of atrial fibrillation with embolization, the prophylaxis and treatment of pulmonary embolism, and as an adjunct in... | Indans / Indenes | |
Dantron | 240.2109 C14H8O4 | A drug used to relieve acute and chronic inflammation of the oral cavity and oropharynx. | Contact Laxatives / Enemas / Laxatives | |
Duloxetine | 297.415 C18H19NOS | A serotonin norepinephrine reuptake inhibitor used to treat generalized anxiety disorder, neuropathic pain, osteoarthritis, and stress incontinence. | Agents producing tachycardia | |
Dolasetron | 324.38 C19H20N2O3 | An antinauseant and antiemetic used in chemotherapy and postoperatively. | Antiemetics / Serotonin 5-HT3 Receptor Antagonists | |
Tolazamide | 311.4 C14H21N3O3S | A sulfonylurea used in the treatment of non insulin dependent diabetes mellitus. | Sulfonylureas | |
Plazomicin | 592.691 C25H48N6O10 | An aminoglycoside antibiotic used to treat complicated urinary tract infections. | Agents that produce neuromuscular block (indirect) / Aminoglycoside Antibacterials / Anti-Bacterial Agents / Antibacterials for Systemic Use / Antiinfectives for Systemic Use / Carbohydrates / Drugs that are Mainly Renally Excreted / Drugs that are Mainly Renally Excreted with a Narrow Therapeutic Index / Gentamicins / Glycosides / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / Narrow Therapeutic Index Drugs / Nephrotoxic agents | |
Dofetilide | 441.565 C19H27N3O5S2 | A class III antiarrhythmic drug used for the maintenance of normal sinus rhythm and cardioversion in cases of atrial fibrillation and atrial flutter. | Antiarrhythmics, Class III | |
Tezacaftor | 520.505 C26H27F3N2O6 | A medication used to treat homozygous or heterozygous F508del mutation cystic fibrosis. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP2B6 Inhibitors / Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C19 Inhibitors / Cytochrome P-450 CYP2C19 inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2D6 Inhibitors / Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Inducers / Cytochrome P-450 CYP3A5 Inducers (strength unknown) / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Dioxoles / Heterocyclic Compounds, Fused-Ring / OAT1/SLC22A6 inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B1/SLCO1B1 Substrates / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / P-glycoprotein substrates | |
Tiagabine | 375.548 C20H25NO2S2 | An antiepileptic used to treat partial seizures. | Fatty Acid Derivatives | |
Paramethadione | 157.1671 C7H11NO3 | Used for the control of absence (petit mal) seizures that are refractory to treatment with other medications. | Oxazolidine Derivatives | |
Talbutal | 224.2563 C11H16N2O3 | For use as a sedative and hypnotic. | Barbiturates, Plain | |
Methylphenobarbital | 246.2619 C13H14N2O3 | For the relief of anxiety, tension, and apprehension, also used as an anticonvulsant for the treatment of epilepsy. | Barbiturates and Derivatives | |
Oxyphenisatin acetate | 401.418 C24H19NO5 | Oxyphenisatin acetate is the pro-drug of oxyphenisatin (3,3-bis(4-hydroxyphenyl)-1H-indol-2-one). The FDA withdrew its approval for the use of oxyphenisatin acetate due to safety reasons. | Indoles / Laxatives | |
Docetaxel | 807.8792 C43H53NO14 | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. | Taxoids | |
Trabectedin | 761.837 C39H43N3O11S | An alkylating agent approved for the treatment of unresectable or metastatic soft tissue sarcoma (liposarcoma or leiomyosarcoma). | Alkylating Drugs / Antineoplastic Agents, Alkylating / Dioxoles / Tetrahydroisoquinolines | |
Losartan | 422.911 C22H23ClN6O | An angiotensin receptor blocker used to treat hypertension and diabetic nephropathy, and is used to reduce the risk of stroke. | Angiotensin II receptor blockers (ARBs) and calcium channel blockers / Angiotensin II receptor blockers (ARBs) and diuretics |
Displaying drugs 2526 - 2550 of 2785 in total